- Home
- CHEB vs DERM Comparison
CHEB vs DERM Comparison
Compare CHEB & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEB
- DERM
- Stock Information
- Founded
- CHEB 2024
- DERM 2014
- Country
- CHEB Singapore
- DERM United States
- Employees
- CHEB N/A
- DERM N/A
- Industry
- CHEB
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- CHEB
- DERM Health Care
- Exchange
- CHEB NYSE
- DERM Nasdaq
- Market Cap
- CHEB 118.7M
- DERM 116.8M
- IPO Year
- CHEB 2024
- DERM 2021
- Fundamental
- Price
- CHEB $10.06
- DERM $4.83
- Analyst Decision
- CHEB
- DERM Strong Buy
- Analyst Count
- CHEB 0
- DERM 3
- Target Price
- CHEB N/A
- DERM $9.50
- AVG Volume (30 Days)
- CHEB 87.4K
- DERM 110.0K
- Earning Date
- CHEB 01-01-0001
- DERM 11-12-2024
- Dividend Yield
- CHEB N/A
- DERM N/A
- EPS Growth
- CHEB N/A
- DERM N/A
- EPS
- CHEB N/A
- DERM N/A
- Revenue
- CHEB N/A
- DERM $57,771,000.00
- Revenue This Year
- CHEB N/A
- DERM N/A
- Revenue Next Year
- CHEB N/A
- DERM $36.49
- P/E Ratio
- CHEB N/A
- DERM N/A
- Revenue Growth
- CHEB N/A
- DERM N/A
- 52 Week Low
- CHEB $9.97
- DERM $2.85
- 52 Week High
- CHEB $26.25
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- CHEB N/A
- DERM 37.41
- Support Level
- CHEB N/A
- DERM $4.88
- Resistance Level
- CHEB N/A
- DERM $5.19
- Average True Range (ATR)
- CHEB 0.00
- DERM 0.31
- MACD
- CHEB 0.00
- DERM -0.06
- Stochastic Oscillator
- CHEB 0.00
- DERM 7.14
About CHEB CHENGHE ACQUISITION II CO
Chenghe Acquisition II Co is a blank check company.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.